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Abstract
Due to their correlation with major human neurological diseases, dopaminergic neurons are some of the most studied
neuronal subtypes. Mesencephalic dopaminergic (mDA) differentiation requires the activation of a cascade of transcription
factors, among which play a crucial role the nuclear receptor Nurr1 and the paired-like homeodomain 3, Pitx3. During
development the expression of Nurr1 precedes that of Pitx3 and those of typical dopaminergic markers such as tyrosine
hydroxylase (TH) and dopamine Transporter (DAT) that are directly regulated by Nurr1. Interestingly we have previously
demonstrated that Nurr1 RNA silencing reduced Pitx3 transcripts, leading to the hypothesis that Nurr1 may control Pitx3
expression. Here we show that Nurr1 overexpression up-regulates that of Pitx3 in a dose-dependent manner by binding to
a non-canonical NBRE consensus sequence, located at the 59 site of the gene. Interestingly, this sequence shows the same
effect as the canonical one in promoting gene translation, and its deletion abolishes the ability of Nurr1 to sustain reporter
gene expression. Moreover, we show that there is a direct interaction between Nurr1 and the Pitx3 gene promoter in
dopaminergic cell cultures and midbrain embryonic tissue. Altogether, our results suggest that the regulation of Pitx3 by
Nurr1 may be an essential event controlling the development and function of mDA neurons.
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Introduction
Mesencephalic dopaminergic (mDA) neurons play a key role in
the motor, reward and emotional behavior of mammals. They are
located in the ventral midbrain forming three distinct nuclei, the
substantia nigra (SN), the ventral tegmental area, and the retrorubral
red nucleus; together they constitute only about 1–5% of the
midbrain cell population [1]. The high incidence of their
degeneration in older people (Parkinson’s disease, PD), as well as
their involvement in widespread neuropsychiatric diseases (schizo-
phrenia or attention deficit hyperactive disorder, ADHD), have
prompted great efforts toward understanding the molecular
mechanisms underlying their specification, differentiation and
maintenance.
During embryonic development in rodents, the activation of
specific genes encoding for transcription factors (TFs) establishes a
molecular code essential for the proper maturation and differen-
tiation of terminal mDA. These include the member 2 nuclear
receptor subfamily 4 group A (Nr4a2 or Nurr1) whose expression
has been detected already at E10.5 in the mouse ventral
mesencephalon [2,3], and the paired-like homeodomain tran-
scription factor 3 (Pitx3) [4,5,6]. Pitx3 is also expressed early during
mDA differentiation, starting at E11 and before the onset of the
typical DA markers. Both TFs persist throughout life, albeit at
lower levels than during development.
Nurr1, differently from Pitx3, whose expression is restricted to
DA neurons [6,7], is also present in other regions of the
mammalian brain, as well as outside the nervous system [8].
Indeed its expression has been detected in non-dopaminergic areas
such as cerebral cortex and hippocampus [9,10] and in microglial
cells [11], where it is involved in the modulation of the
inflammatory response. Thus these findings suggest that it could
exert a wider transcriptional control than that described for the
mDA system.
The key role of Nurr1 during mDA phenotype development
and survival has been highlighted by conventional knock-out
mouse model and by conditional deletion [12]. In both cases it
has been shown that the deletion of Nurr1 determines the
progressive loss of mDA neurons, suggesting that its presence is
essential for maintenance of the dopaminergic specification
throughout the entire DA neuron lifespan. On the other hand,
the alteration of Pitx3 in the naturally occurring mouse mutant
aphakia shows a selective depletion of mDA neurons in the
substantia nigra [4,6].
The mechanism of action of Nurr1 has been dissected in vitro
and a number of its target genes in mDA neurons have been
identified, including tyrosine hydroxylase (TH), vesicular monoamine
transporter 2 (Vmat2), dopamine transporter (DAT), Neuropilin, and brain
derived neurotrophic factor (Bdnf) [13–17]. Some of these genes, such as
Vmat2, TH and DAT, are targets of Pitx3 as well [18]. The
involvement of both TFs in the regulation of crucial mDA genes
suggests that these proteins might cooperate and participate in
several processes during mDA neuron development, but their
hierarchical relationship remains unknown.
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enriched in mDA neurons, that silencing Nurr1 determines a
significant decrease of Pitx3 expression similar to that observed for
other gene targets of Nurr1 such as Bdnf and TH [17]. This finding
has prompted us to investigate if the expression level of Pitx3 may
depend on Nurr1. Here we show that Nurr1 directly regulates
Pitx3 expression by binding to a specific Nurr1-binding region
located in the Pitx3 gene promoter.
Results
Overexpression of Nurr1 up-regulates Pitx3 mRNA and
protein
To investigate whether or not Nurr1 affects Pitx3 expression we
used the MN9D-Nurr1
Tet-On cell line, which expresses Nurr1
under a tetracycline-inducible promoter [13]. MN9D cells have
already been used as the cellular model system to study the
development and maturation of mDA neurons. They are able to
synthesize and release dopamine, and after Nurr1 overexpression
acquire a more pronounced dopaminergic phenotype by boosting
the expression of the dopaminergic-related markers such as TH
and Vmat2 [13]. Following Nurr1 hyper-expression by doxycycline
treatment (Figure 1A) we observed a two-fold enrichment in Pitx3
mRNA, when compared to control cultures (Figure 1B). To
confirm the role of Nurr1 as an inducer of the DA phenotypes we
observed a parallel up-regulation of the levels of TH and Vmat2
mRNA, in agreement with previous data (Figure 1B) [13].
Since the expression of Pitx3 was only slightly increased by dox-
mediated overexpression of Nurr1 we replicated similar experi-
ments by transfecting the parental MN9D cell line with a
36FLAG-Nurr1 plasmid, which gave a more sustained Nurr1
expression (Figure 1C). As shown in Figure 1D the up-regulation
of Pitx3 was proportional to the amount of the Nurr1-expressing
plasmid when compared to cells transfected with an empty vector.
Under these conditions we observed an increase of Pitx3 mRNA
up to 3.5 times above the control. Similarly Vmat2 and TH
mRNAs were also up regulated and their higher level of expression
was achieved at a lower concentration of Nurr1 plasmid, reaching
a plateau at about 50 ng/well. (Figure 1E–F, respectively).
An increase of Pitx3, up to 50%, was also observed at the
protein level (Figure 2A) with respect to untreated samples. Such
up-regulation was observed both in MN9D-Nurr1
Tet-On cells upon
doxycycline treatment and MN9D cells after Nurr1 transfection.
The relative expression of Pitx3 was assessed by quantifying
proteins bands, under the various experimental conditions, and
normalized to ß-actin. Similar results were obtained by using the
Neuronal Class III ß-Tubulin (TUJ1) as internal control
(Figure 2A).
Since Nurr1 can regulate transcription either as a monomer or
as a heterodimer with retinoid X receptor (RXR) [19], we
investigated whether the effects of Nurr1 on Pitx3 expression were
modified upon dimerization of Nurr1 with RXR. First we
established that RXR alone was unable to increase Pitx3 mRNA
above control levels (Figure 2B); then we co-transfected Nurr1 and
RXRa to assess for the existence of any synergic effect. As shown
in Figure 2B, the co-expression of Nurr1 and RXRa does not
modify Pitx3 mRNA levels, thus suggesting that Nurr1 acts as
either a monomer or homodimer in controlling Pitx3 translation.
The mouse Pitx3 promoter is responsive to Nurr1
We then investigated if Nurr1 could control the expression of
Pitx3 at the transcriptional level. By performing in silico analysis of
the Pitx3 promoter region we did not find canonical NBRE
sequences (AAAGGTCA), known to be essential for Nurr1
binding. Instead our analysis revealed a potential consensus motif,
located 220 base pairs (bp) upstream the transcription initiation
site that differs from the canonical NBRE for the insertion of a T
right after the central core (AAAGGTTCA; Figure 3A). We
renamed this sequence NBRE-like. To assess whether Nurr1 could
directly interact with the Pitx3 promoter and stimulate transcrip-
tion, we cloned the 700 bp region in a reporter vector above the
Pitx3 transcription initiation site, and verified that it contained the
NBRE-like region by sequencing it. To assess that it could trigger
transcription, we performed a luciferase assay in the human cell
line HeLa. As shown in Figure 3B, Nurr1 was able to activate
transcription of the luc-gene under the control of the Pitx3
promoter. This activation was specific for Nurr1 since vectors
expressing Coup-TF1 (chicken ovalbumin upstream promoter
transcription factor 1), a member of the nuclear receptor
transcription factor superfamily, or an unrelated protein such as
the alpha-synuclein, were unable to promote luciferase expression
(Figure 3C).
Next, to understand whether the ability of the NBRE-like
consensus site to promote reporter gene expression was compa-
rable to that of the NBRE, we restored the canonical motif by
deleting the extra T (construct N1; AAAGGTTCA in
AAAGGTCA). As we hypothesized, this mutation did not modify
the ability of the Pitx3 promoter to activate the reporter
transcription. These data confirm that the NBRE-like region is
able to bind Nurr1 and thus activate transcription of the
downstream gene, with efficiency comparable to the NBRE
sequence. In addition, the transcriptional stimulation triggered by
the NBRE-like sequence was comparable to that obtained by using
a construct carrying three repeated NBRE binding sites (36-
NBRE) (Figure 3D). Finally, to further confirm that the NBRE-like
region was the only Nurr1-dependent sequence able to promote
Pitx3 gene transcription, we deleted the 20 bp containing this
region (gggcctAAAGGTTCAcagct). As expected, the deletion
abolished over 70% of the luciferase expression (Figure 3D).
These data confirm that the NBRE-like sequence we identified
on the Pitx3 promoter is a proper target of Nurr1.
Nurr1 regulates Pitx3 expression by binding to its
promoter
We performed a chromatin immunoprecipitation (ChIP) assay
to demonstrate that Nurr1 can bind the genomic NBRE-like
sequence upstream to Pitx3. Indeed by using the immunoprecip-
itate from MN9D cells overexpressing 36FLAG-Nurr1, we were
able to show a significant enrichment of the Pitx3 promoter
fragment containing the NBRE-like sequence, either by PCR
(Figure 4A) or real time PCR (Figure 4B). We also probed this
same immunoprecipitate for the presence of promoter regions of
other Nurr1 target genes such as Bdnf, Vmat2 and TH, and found
that they were all enriched. As expected, no enrichment was
observed when we amplified a part of Vmat2 promoter that did
not contain the Nurr1 consensus sequence.
In order to confirm that Nurr1 binds to the NBRE-like
sequence on the Pitx3 also in vivo, we repeated the ChIP analysis
on mouse ventral midbrain tissue during embryonic development
(at E14.5). This time point was chosen since the highest Nurr1
expression takes place at this developmental stage in this region.
We observed a significant enrichment of the Pitx3 promoter
fragment containing the NBRE-like sequence, even higher (about
seven-fold) than that observed in cell cultures (Figure 4C–D). In
addition we found a four-fold enrichment of the Bdnf promoter
region (Figure 4C–D), as expected [17].
Altogether, these data strongly support a direct regulation of
Pitx3 expression by Nurr1.
Nurr1 Regulates Pitx3 Expression
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e30661Figure 1. Overexpression of Nurr1 up-regulates Pitx3, TH and Vmat2 mRNAs. Transcriptional analysis performed by real time PCR of Nurr1,
Pitx3, TH and Vmat2 in MN9D cells treated with 3 mg/ml of doxycycline (dox, A, B) or with different concentrations (ng) of 36FLAG-Nurr1 plasmid
(C, D, E, F). The diagrams (C–F) show the mRNA levels of Nurr1, Pitx3, TH and Vmat2 over an empty vector as control (dotted lines, mean6SE).
Expression levels are presented as the relative number of copies compared with the Hprt transcript using the comparative threshold cycle (CT)
method (2
2DDCT). Asterisks (*) represent p#0.01 when compared to relative controls (ANOVA, Scheffe ` F-test).
doi:10.1371/journal.pone.0030661.g001
Nurr1 Regulates Pitx3 Expression
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During ontogeny, the midbrain regional identity requires the
action of a complex transcriptional program involving among
others the TFs Lmx1a, Lmx1b, Pitx3 and Nurr1 [20]. This last TF
appears to be a major player in the control of the mDA phenotype,
through the regulation of several proteins required for dopami-
nergic function. However, it has been shown that also Pitx3 is able
to promote the expression of DA genes, suggesting a role for both
TFs as players acting on the same pathways. Thus several
approaches have been used, aimed at clarifying the reciprocal roles
of the transcription factors Nurr1 and Pitx3 in promoting the
differentiation of mDA neurons. By using molecular and cellular
approaches, a number of common downstream target genes of
both proteins have been identified, such as the vesicular
transporter Vmat2 and the plasma membrane transporter DAT
[13,16]. In addition Nurr1 2/2 mice display the absence of TH
+
neurons in the ventral midbrain, because their development is
incomplete [21]. Indeed a few cells transiently expressed Pitx3 in
this area but disappeared shortly thereafter leading to two
alternative hypotheses: either Nurr1 expression is required to
maintain Pitx3 levels, or Pitx3 expression is independent of Nurr1
and is lost by the early death of the mDA neurons. Moreover the
combined transduction of Nurr1 and Pitx3 promotes the matura-
tion of ES cells into a dopaminergic phenotype [22]. These
observations have prompted the idea that a hierarchical
relationship could exist between Nurr1 and Pitx3, or alternatively
that both transcription factors could cooperate at the protein level
in controlling the dopaminergic transcription machinery.
Since in previous Nurr1 silencing experiments we observed a
reduction of Pitx3 mRNA, we were prompted to investigate
whether and how Nurr1 could modulate the expression of Pitx3.
Here we show that Nurr1 can increase Pitx3 transcripts and that
this effect is achieved by the specific binding of Nurr1 to a non-
canonical NBRE element located 220 bp upstream the transcrip-
tion initiation site on the Pitx3 promoter. By using multiple
approaches involving overexpression of Nurr1 in a dopaminergic
cell line, luciferase reporter assay and chromatin immunoprecip-
itation, in both culture and embryonic midbrain tissues, we
provide evidence that Nurr1 does indeed promote Pitx3 expres-
sion. Thus we suggest that Nurr1 controls the specification of the
dopaminergic phenotype also by modulating Pitx3. These findings
are not in contrast with the hypothesis that Nurr1 could interact
with Pitx3 at the protein level either directly or through a third
partner, to regulate common target genes, as has been suggested
by others [22,23]. Thus Pitx3 regulation could take place at various
levels, and at least in part, appears to be regulated by Nurr1 in
mDA neurons.
In synthesis, our report sheds new light on the role of Nurr1 in
mDA neuron differentiation and maintenance, positioning this TF
at a high hierarchical level in the regulation of this neuronal
phenotype.
Methods
Cell lines
The MN9D-Nurr1
Tet On cell line was kindly provided by
Thomas Perlmann [13]. Cells were maintained at 37uC, with 5%
CO2 in DMEM/F12 medium (Life Technologies, Milan, Italy)
supplemented with 10% FBS (Euroclone, Milan, Italy), 100 U/ml
penicillin and 100 mg/ml streptomycin (Sigma, Milan, Italy). Cells
were grown in poly-D-lysine (Sigma) coated flasks as previously
described. Nurr1 expression was induced by addition of 3 mg/ml
doxycycline (Sigma) to the culture medium or with 36FLAG-
Nurr1 transfection. Cells were grown as above except that the
10% serum was changed in B27 supplement (Life Technologies).
Nurr1 expression was induced by addition of 3 mg/ml doxycycline
(Sigma). HeLa cells (ATCC, LGC Standards, Italy) and MN9D
[24] were used as well.
Plasmids construction
Pitx3 promoter (pPitx3) sequence, analyzed using MatInspector
Release professional 8.0 from Genomatix software package
(GmbH, Munich, Germany, http://www.genomatix.de/), was
amplified and cloned in pGL3-basic firefly luciferase reporter
vector (Promega, Milan, Italy). The plasmid pGL3-pPitx3
sequence was confirmed by sequencing. Mutant constructs of
pPitx3 were generated with the Quick-change site-direct muta-
genesis kit (Stratagene), according to the manufacturer’s protocol.
Flag-tagged full-length (FL) mouse Nurr1, cloned into 36FLAG
vector (Sigma), was kindly provided by Kaoru Saijo [11]. Full-
length (FL) of human RXRa was kindly provided by Philip
Lefevbre [25].
Figure 2. Pitx3 up-regulation depends of Nurr1 overexpres-
sion. (A) Pitx3 protein expression in MN9D treated or not (ctrl) with
3 mg/ml of doxycycline (dox) and transfected with the 36FLAG-Nurr1
expressing vector (Nurr1) or with an empty vector (36FLAG). The
diagram shows the relative quantitation (mean6SE) of Pitx3 protein
compared to that of ß-actin. The relative abundance of the Neuronal
Class III b-Tubulin (TUJ1) is shown as an additional loading control. Data
are expressed as ratio Pitx3/ß-actin. Inserts show a representative
western blot of Pitx3, ß-actin and TUJ1. (B) Pitx3 mRNA level in MN9D
cells transfected with: 36FLAG-Nurr1 (Nurr1), psg5-RXR (RXRa), or both
constructs (Nurr1+RXRa). The diagram shows Pitx3 mRNA level
(mean6SE) relative to Hprt (2
2DDCT). Asterisks (*) represent p#0.01
when compared to controls (ANOVA, Scheffe ` F-test).
doi:10.1371/journal.pone.0030661.g002
Nurr1 Regulates Pitx3 Expression
PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e30661Transient transfection and luciferase assay
700 bps region upstream the 59UTR of the Pitx3 promoter was
cloned into a pGL3 basic vector (pPitx3-luc) and co-transfected
with the 36FLAG-Nurr1 plasmid into HeLa cells using lipofecta-
mine 2000, according to the manufacturer’s protocol. Renilla
luciferase vector, carrying the Simian vacuolating virus 40
promoter (pRL-SV40), were used as an internal control. For the
dual (firefly and Renilla) luciferase assays, cells were extracted with
passive lysis buffer (Promega), and 10 ml of cell extract was used
according to the manufacturer’s protocol. Values were expressed
as a ratio of luminescence signals between the luciferase reporter
and the Renilla. The data were performed in triplicate.
RNA isolation and Real time PCR
Total RNA was isolated using Tri-Reagent (Sigma, Milan, Italy)
according to the manufacturer’s instructions. The analyses were
always carried out in triplicate samples for each experimental
point analyzed and were processed separately. The yield and
integrity of RNA were determined by spectrophotometric
measurement of A260 and agarose gel electrophoresis respectively.
Briefly, 2 mg of RNA were reverse transcribed, using random
hexanucleotides (New England Biolabs Inc., Milan, Italy, 6 mM)
and 200 U of Moloney-murine leukemia virus reverse transcrip-
tase (Ambion). Gene specific primer sets (Table 1) used for
quantitative real time PCR (qRT-PCR, Applied Biosystem, Milan,
Italy) were designed using OLIGO 6 software according to
manufacturer’s instructions, in order to obtain amplified fragments
with comparable length (around 100 bp). SYBR Green qRT-PCR
reactions were performed in 96-well plates using 7900HT Fast
Real-Time PCR System (Applied Biosystem). Thermal cycling
conditions comprised initial steps at 50uC for 2 minutes and 95uC
for 10 minutes, followed by 40 cycles at 95uC for 15 seconds and
60uC for 1 minute. All samples were run in triplicate. Amplifica-
tion efficiency of each primer pair was verified by performing
qRT-PCR using different template dilutions. Gene expression
levels were quantified from real-time PCR data by the compar-
ative threshold cycle (CT) method [26] using hypoxanthine
phosphoribosyl transferase (HPRT) as an internal control gene.
The fractional number of PCR cycles CT required to obtain a
given amount of qRT-PCR product in the exponential phase of
amplification was determined for the gene of interest and for
HPRT in each RNA sample. The relative expression level of the
gene of interest was then expressed as 2
2DDCT where DCT=CT
gene of interest - CT HPRT.
Figure 3. The mouse Pitx3 promoter is responsive to Nurr1. (A) Schematic representation of the mouse Pitx3 gene indicating the position of
NBRE-like binding sites in Pitx3 promoter. (B) Luciferase assay in HeLa cells co-transfected with the Pitx3 promoter–reporter vector and with increasing
concentration of 36FLAG-Nurr1 plasmid. (C) The Pitx3 promoter activation is specific for Nurr1 since vectors expressing Coup-TF1 (chicken ovalbumin
upstream promoter Transcription Factor 1) or alpha-synuclein (a-syn) were unable to promote luciferase expression. (D) Scheme of the promoter–
reporter gene constructs used. We named: i) ‘‘NBRE-like’’ the promoter with the endogenous sequence; ii) ‘‘N1’’ the endogenous promoter deleted of
the extra T to restore the canonical NBRE sequence; iii) ‘‘N2’’ the endogenous promoter deleted of the entire NBRE-like region. As positive control we
used a reporter vector expressing three times the canonical NBRE sequence (36-NBRE). The histogram shows similar luciferase activation when NBRE-
like, N1 or 36-NBRE constructs were used. The deletion of the entire NBRE-like region (N2) significantly reduced luciferase expression. The ratio of
firefly luciferase/Renilla activity is expressed as relative increase over control (dotted lines). The results are expressed as mean 6 SE; asterisks
(*) represent p#0.01 when compared to control (ANOVA, Scheffe ` F-test).
doi:10.1371/journal.pone.0030661.g003
Nurr1 Regulates Pitx3 Expression
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For Western blot analyses three different cultures samples were
lysed in RIPA Buffer in presence of protease inhibitors (Roche,
Milan, Italy). 50 mg/lane of proteins were separated on 12% SDS-
polyacrilamide gel and transferred to PVDF membranes (Amer-
sham, Milan, Italy). Filters were probed for 2 hrs at room
temperature or overnight at 4uC with the following antibodies:
anti-Nurr1/Nur77 (E-20 sc-990 X, Santa Cruz Biotechnology
Inc., Milan, Italy, 1: 5000), anti-ß-actin (Sigma, 1:1000), anti-Pitx3
(Abcam, Cambridge, UK 1:250), anti-Neuronal Class III ß-
Tubulin (TUJ1, Convance, Milan, Italy, 1:1000). After washing,
immunoblots were incubated with goat anti-rabbit (Bio-Rad,
1:1500) or anti-mouse IgG antibodies (Amersham, 1:5000) and the
reaction detected with the ECL plus procedure (Amersham). The
relative protein levels were determined by densitometry and
compared with the protein level of ß-actin and TUJ1 either in
control or in treated cells.
Chromatin Immunoprecipitation (ChIP)
5610
6 MN9D cells were transfected with 36FLAG-Nurr1
using lipofectamine 2000, fixed 24 hrs post transfection with 1%
formaldehyde for 15 min at r/t and the reaction stopped by
addition of 125 mM glycine for 5 min. The pellets, washed in cold
PBS with proteinase inhibitors, were lysed in 5 ml of Lysis Buffer
[5 mM Pipes pH 8.0, 85 mM KCl, 0.5% NP40 and proteinase
inhibitors]. After the centrifugation at 2000 rpm for 5 min, nuclei
were dissolved in High Salt Lysis Buffer [HSLB- 16PBS, 1% NP-
40, 0.5% Sodium Deoxycholate, 0.1% SDS and Protease Inhibitor
Figure 4. Nurr1 directly regulates Pitx3 expression by binding to its promoter. (A) ChIP-PCR analysis performed in MN9D transfected with
36FLAG-Nurr1 and immunoprecipitated with anti-FLAG antibody shows a significant enrichment of Pitx3, Bdnf and Vmat2 promoter regions. No
enrichment was observed when an unrelated region of the Vmat2 promoter was used [19]. The inserts show representative PCR amplified fragments
after ChIP. (B) ChIP-Real time PCR in MN9D transfected with 36FLAG-Nurr1 and immunoprecipitated with anti-FLAG antibody. The diagram shows
the fold enrichment over background (dotted line) for Pitx3, Bdnf and Vmat2 promoter regions. (C) ChIP-PCR validation performed in E14.5 midbrain
and immunoprecipitated with Nurr1 antibody shows a significant enrichment of the Pitx3 and Bdnf promoter regions. A representative PCR amplified
fragment is shown into the insert. (D) The diagram shows the ChIP-Real time PCR quantitation of Bdnf and Pitx3 promoter region in E14.5 midbrain
and immunoprecipitated with Nurr1 antibody. Results are expressed as mean 6 SE of at least three independent experiments. Asterisks (*) represent
p#0.01 when compared to control (ANOVA, Scheffe ` F-test).
doi:10.1371/journal.pone.0030661.g004
Table 1. Primers (59-39) used for Real time-PCR.
Gene of interest Primers Sequence
Hprt F: TGGGAGGCCATCACATTGT
R: AATCCAGCAGGTCAGCAAAGA
Nurr1 F: CAACTACAGCACAGGCTACGA
R: GCATCTGAATGTCTTCTACCTTAATG
Pitx3 F: GACACTGGCCGCCCAAGG
R: AGGCCCCACGTTGACCGA
TH F: CCTTTGACCCAGACACAGCA
R: ATACGAGAGGCATAGTTCCTGAG
Vmat2 F: TTGCTCATCTGTGGCTGGG
R: TGGCGTTACCCCTCTCTTCAT
The table shows the forward (F) and reverse (R) primers used in Real time PCR
for the following genes: hypoxanthine-phosphoribosyl-transferase (Hprt), Nurr1,
the paired-like homeodomain transcription factor 3 (Pitx3), tyrosine hydroxylase
(TH), vesicular monoamine transporter 2 (Vmat2).
doi:10.1371/journal.pone.0030661.t001
Nurr1 Regulates Pitx3 Expression
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fragments from 200–1000 bp, cells debris removed by centrifuga-
tion and samples pre-cleared with 50 ml Protein A/G Plus-Agarose
(Santa Cruz Biotechnology, sc-2003) for 2 hrs at 4uC. Immuno-
precipitations of cross-linked complexes were performed by
overnight incubation at 4uC using 1 mg of goat anti- Nurr1/
Nur77 antibody (E-20 sc-990 X, Santa Cruz Biotechnology) or
1.5 mg of anti-mouse 36FLAG antibody (Sigma). For each
experiment, a sample without antibody was carried out in parallel
as a control for nonspecific background. Protein A/G Plus-
Agarose (50 ml) were added, incubated at 4uC for 2 hrs, spun at
2000 rpm, washed twice in HSLB, four times in Wash Buffer
[100 mM Tris (pH 8.0), 500 mM LiCl, 1% NP-40 and 1%
Deoxycholate]. The supernatant of bound and unbound samples
was then incubated at 67uC in 100 mM NaHCO3 and 1% SDS to
elute immune complexes. DNA was phenol-chloroform extracted,
ethanol precipitated, UV quantified, and used for PCR or Real
Time with primers spanning the NBRE-like sites in pGL3-pPitx3.
Statistical analysis
The analyses data have been described above. For all other
experiments, analysis of variance was carried out, followed by post
hoc comparison (ANOVA, Scheffe ` F-test). Data were expressed as
mean +/2 SEM.
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